Evidence map›Paper›PMID 31372774›Full record

ArticleNeurogenetics2019

Homozygous frameshift variant in NTNG2, encoding a synaptic cell adhesion molecule, in individuals with developmental delay, hypotonia, and autistic features.

Bassam Abu-Libdeh, Motee Ashhab, Maher Shahrour, Muhannad Daana, Anwar Dudin, Orly Elpeleg, Simon Edvardson, Tamar Harel

Abstract read
PubMed Publisher
In one paragraph

Article in Neurogenetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. ProteinMolecules (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bassam Abu-LibdehDepartment of Pediatrics, Makassed Hospital and Al-Quds University, East Jerusalem, Palestine.
Motee AshhabDepartment of Pediatrics, Makassed Hospital and Al-Quds University, East Jerusalem, Palestine.
Maher ShahrourDepartment of Pediatrics, Makassed Hospital and Al-Quds University, East Jerusalem, Palestine.
Muhannad DaanaChild Development Centers, Clalit and Maccabi Health Care Services, Jerusalem, Israel.
Anwar DudinConsultant Pediatric Neurologist, Takween Center, Ramallah, Palestine.
Orly ElpelegMonique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, 9112001, Jerusalem, Israel.
Simon EdvardsonMonique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, 9112001, Jerusalem, Israel.
Tamar HarelDepartment of Genetic and Metabolic Diseases, Hadassah-Hebrew University Medical Center, POB 12000, 9112001, Jerusalem, Israel. tamarhe@hadassah.org.il.ORCID 0000-0003-3595-7075

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulation of neuronal connectivity and synaptic communication are key to proper functioning of the brain. The Netrin-G subfamily and their cognate receptors are vertebrate-specific synaptic cell adhesion molecules with a role in synapse establishment and function, which seem to have co-evolved to contribute to higher brain functions. We identified a homozygous frameshift variant in NTNG2 (NM_032536.3: c.376dup), encoding Netrin-G2, in eight individuals from four families with global developmental delay, hypotonia, secondary microcephaly, and autistic features. Comparison of haplotypes established this as a founder variant. Previous studies showed that Ntng2-knockout mice have impaired visual, auditory, and motor coordination abilities required for demanding tasks, as well as possible spatial learning and memory deficits. Knockout of Ntng2 in a cellular model resulted in short neurites, and knockout of its trans-synaptic partner Ngl2/Lrrc4 in mice revealed autistic-like behavior and reduced NMDAR synaptic plasticity. The Ngl2/Lrrc4-knockout mouse phenotype was rescued by NMDAR activation, suggesting a mechanistic link to autism spectrum disorder. We thus propose NTNG2 as a candidate disease gene and provide further support for the involvement of Netrin-G2 in neuropsychiatric phenotypes.

Indexed as

Frameshift MutationHomozygoteAutistic DisorderCell AdhesionCell Adhesion MoleculesChildDevelopmental DisabilitiesExomeFemaleGPI-Linked ProteinsHaplotypesHumansMaleMuscle HypotoniaNetrinsNeuronal PlasticityCell Adhesion MoleculesGPI-Linked ProteinsNetrinsNTNG2 protein, humanAutism spectrum disorderExome sequencingNetrin familyNTNG2Synaptic adhesion molecules

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.